Medgenics Company Profile (NYSEMKT:MDGN)

About Medgenics

Medgenics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: MDGN
  • CUSIP:
Key Metrics:
  • Previous Close: $5.02
  • 50 Day Moving Average: $5.30
  • 200 Day Moving Average: $5.47
  • 52-Week Range: $3.09 - $7.57
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.89
  • P/E Growth: 0.00
  • Market Cap: $186.13M
  • Outstanding Shares: 37,078,000
  • Beta: 0.67
Additional Links:
Companies Related to Medgenics:

Analyst Ratings

Consensus Ratings for Medgenics (NYSEMKT:MDGN) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50

Analysts' Ratings History for Medgenics (NYSEMKT:MDGN)
DateFirmActionRatingPrice TargetDetails
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$15.00 -> $13.00View Rating Details
11/12/2015Needham & Company LLCInitiated CoverageBuy$12.00View Rating Details
1/20/2015Piper Jaffray Cos.Boost Price TargetBuy$7.00 -> $11.50View Rating Details
(Data available from 10/25/2014 forward)


Earnings History for Medgenics (NYSEMKT:MDGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2016Q116($0.26)($0.34)ViewListenView Earnings Details
2/17/2016Q415($0.28)($0.20)ViewListenView Earnings Details
10/22/2015Q315($0.31)($0.33)ViewListenView Earnings Details
8/10/2015Q215($0.34)($0.28)ViewN/AView Earnings Details
4/17/2015Q115($0.34)($0.36)$2.14 million$3.90 millionViewListenView Earnings Details
2/13/2015Q414($0.22)($0.30)ViewListenView Earnings Details
10/15/2014Q3($0.25)($0.21)ViewListenView Earnings Details
7/16/2014Q214($0.23)($0.21)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Medgenics (NYSEMKT:MDGN)
Current Year EPS Consensus Estimate: $-1.30 EPS
Next Year EPS Consensus Estimate: $-1.29 EPS


Dividend History for Medgenics (NYSEMKT:MDGN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Medgenics (NYSEMKT:MDGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/6/2015Joseph J Grano JrDirectorBuy15,384$6.50$99,996.00View SEC Filing  
10/6/2015Michael F ColaCEOBuy38,460$6.50$249,990.00View SEC Filing  
9/21/2015Isaac BlechDirectorSell94,825$9.96$944,457.00View SEC Filing  
3/20/2015Eugene A BauerDirectorSell50,000$8.45$422,500.00View SEC Filing  
2/20/2015Sol J BarerDirectorBuy150,000$7.44$1,116,000.00View SEC Filing  
12/1/2014Alastair J T ClemowDirectorBuy12,195$4.10$49,999.50View SEC Filing  
12/1/2014Michael F ColaCEOBuy60,976$4.10$250,001.60View SEC Filing  
12/1/2014Scott ApplebaumInsiderBuy6,098$4.10$25,001.80View SEC Filing  
6/13/2014Sol J BarerDirectorBuy28,000$7.96$222,880.00View SEC Filing  
5/12/2014Sol J BarerDirectorBuy60,000$6.91$414,600.00View SEC Filing  
2/4/2014Andrew PearlmanDirectorSell20,000$8.00$160,000.00View SEC Filing  
1/30/2014Andrew PearlmanDirectorSell25,000$7.50$187,500.00View SEC Filing  
1/9/2014Andrew PearlmanDirectorSell80,000$6.60$528,000.00View SEC Filing  
12/16/2013Alastair J T ClemowDirectorBuy4,500$5.78$26,010.00View SEC Filing  
12/13/2013Sol J BarerDirectorBuy20,000$5.37$107,400.00View SEC Filing  
12/6/2013Clarence L DellioCOOSell2,000$6.50$13,000.00View SEC Filing  
12/3/2013Eugene A BauerDirectorSell20,000$6.30$126,000.00View SEC Filing  
12/2/2013Sol J BarerDirectorBuy20,000$6.59$131,800.00View SEC Filing  
11/11/2013Sol J BarerDirectorBuy25,000$6.80$170,000.00View SEC Filing  
9/20/2013Sol J BarerDirectorBuy20,000$6.50$130,000.00View SEC Filing  
9/19/2013Sol J BarerDirectorBuy20,000$5.57$111,400.00View SEC Filing  
6/4/2013Clarence L DellioCOOBuy1,000$4.14$4,140.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Medgenics (NYSEMKT:MDGN)
DateHeadline logoMain Line gene therapy company is trading exchanges (NYSEMKT:MDGN) - October 12 at 6:03 PM logoMEDGENICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T (NYSEMKT:MDGN) - October 11 at 6:22 PM logoMedgenics, Inc. to Begin Trading on NASDAQ Global Market (NYSEMKT:MDGN) - October 10 at 5:46 PM logoMedgenics, Inc. (MDGN) (NYSEMKT:MDGN) - October 3 at 5:45 PM logoMedgenics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference (NYSEMKT:MDGN) - September 6 at 10:49 AM logoMEDGENICS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (NYSEMKT:MDGN) - August 4 at 6:27 PM
News IconMedgenics Reports Second Quarter 2016 Financial Results (NYSEMKT:MDGN) - August 4 at 9:14 AM logoMedgenics reports 2Q loss (NYSEMKT:MDGN) - August 4 at 9:14 AM logoMedgenics to Host Conference Call to Announce Second Quarter 2016 Financial Results (NYSEMKT:MDGN) - July 27 at 12:18 PM logo$20M stock sale: Gene therapy company raising funds for rare disease treatments (NYSEMKT:MDGN) - June 22 at 9:55 AM logoWhy Medgenics Inc.'s Shares Are Down Big Today (NYSEMKT:MDGN) - June 21 at 5:46 PM logoPre-Open Stock Movers 06/21: (ROSG) (CDXC) (OPK) Higher; (SCYX) (WERN) (SWFT) Lower (more...) (NYSEMKT:MDGN) - June 21 at 10:36 AM logoMedgenics (MDGN) Plans Common Stock Offering (NYSEMKT:MDGN) - June 21 at 10:36 AM logoMedgenics Announces Pricing of Public Offering of Common Stock (NYSEMKT:MDGN) - June 21 at 9:29 AM logoMedgenics Announces Public Offering of Common Stock (NYSEMKT:MDGN) - June 20 at 4:19 PM logoMEDGENICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure (NYSEMKT:MDGN) - June 17 at 4:31 PM logoMedgenics Announces Enrollment of First Patient in Phase 2/3 Clinical Trial of NFC-1 in Adolescents With mGluR Mutation Positive ADHD (NYSEMKT:MDGN) - June 17 at 8:29 AM logoMDGN Adds Another High-Potential Orphan Candidate (NYSEMKT:MDGN) - June 7 at 4:30 PM logoMedgenics, Inc. :MDGN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NYSEMKT:MDGN) - June 6 at 2:28 PM logoMedgenics, CHOP & Japanese biopharm firm team up to take on rare pediatric disease (NYSEMKT:MDGN) - June 6 at 11:10 AM logoMedgenics Obtains Rights to First-in-Class Biologic for Severe Pediatric Onset IBD (NYSEMKT:MDGN) - June 6 at 7:08 AM logoMEDGENICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NYSEMKT:MDGN) - June 6 at 7:02 AM logo7:02 am Medgenics enters collaboration with Kyowa Hakko Kirin for the development and commercialization of its anti-LIGHT monoclonal antibody (NYSEMKT:MDGN) - June 6 at 7:02 AM logoMedgenics to Present at the Jefferies 2016 Global Healthcare Conference (NYSEMKT:MDGN) - June 1 at 8:53 AM logoRevenue Update on Medgenics Inc(NYSEMKT:MDGN) - Trade Calls (NYSEMKT:MDGN) - May 21 at 1:38 PM
News IconMedgenics Inc (NYSEMKT:MDGN) Stock Price Up as Sentiment Increases - Wall Street Hints and News (NYSEMKT:MDGN) - May 18 at 2:22 PM logoStock Highlights: Medgenics, Inc. (NYSEMKT:MDGN), Summer Infant, Inc. (NASDAQ:SUMR), Potlatch Corporation ... - KC Register (NYSEMKT:MDGN) - May 10 at 7:58 AM logoQ1 2016 Medgenics Inc Earnings Release - Before Market Open (NYSEMKT:MDGN) - May 10 at 7:07 AM
News IconNext Weeks Broker Price Targets For Medgenics, Inc. (MDGN) - Share Trading News (NYSEMKT:MDGN) - May 9 at 7:58 AM
News IconMedgenics Incorporated (NYSEMKT:MDGN) Sellers Covered 1.1% of Their Shorts - B.O.D.Y Confidential (NYSEMKT:MDGN) - May 7 at 7:43 AM logoTop Stories: Medgenics (NYSEMKT:MDGN), Cellectar Biosciences (NASDAQ:CLRB), Royal Caribbean Cruises Ltd ... - KC Register (NYSEMKT:MDGN) - May 2 at 7:57 AM
News IconBroker Outlook For The Week Ahead: Medgenics, Inc. (MDGN) - Share Trading News (NYSEMKT:MDGN) - May 2 at 7:57 AM
News IconMedgenics, Inc. (MDGN) Updated Broker Price Targets - Share Trading News (NYSEMKT:MDGN) - April 29 at 8:36 AM
News IconNew Analyst Ratings On Medgenics, Inc. (MDGN) - Risers & Fallers (NYSEMKT:MDGN) - April 27 at 9:13 AM
News IconUpgrades And Downgrades For Medgenics, Inc. (MDGN) - Risers & Fallers (NYSEMKT:MDGN) - April 23 at 8:15 AM logoMedgenics Hires Eric Phillips, MPH, ScD as Vice President of Regulatory Affairs (NYSEMKT:MDGN) - April 20 at 8:21 AM
News IconMedgenics Incorporated (NYSEMKT:MDGN) Shorts Decreased by 0.69% After Short Covering - (NYSEMKT:MDGN) - April 19 at 9:18 AM
News IconLatest Analyst Ratings For Medgenics, Inc. (MDGN) - Share Trading News (NYSEMKT:MDGN) - April 15 at 12:01 PM
News IconMedgenics Inc (NYSEMKT:MDGN) Institutional Investors Sentiment Change - (NYSEMKT:MDGN) - April 14 at 1:22 PM
News IconShort Interest in Medgenics Inc (MDGN) Decreases By 0.7% - Washington News Wire (NYSEMKT:MDGN) - April 13 at 2:08 PM
News IconMedgenics, Inc. (MDGN) Latest Broker Coverage - Risers & Fallers (NYSEMKT:MDGN) - April 11 at 2:54 PM
News IconDoes Medgenics Inc Have Any Gas After Today's Huge Decline? - Business Standard Tribune (NYSEMKT:MDGN) - April 9 at 11:22 AM logoMedgenics Inc (NYSEMKT:MDGN)'s Company Shares Increased 14.11% After High Volatility - Clinton Financial (NYSEMKT:MDGN) - April 7 at 12:30 PM
News IconBroker Roundup For Medgenics, Inc. (MDGN) - Share Trading News (NYSEMKT:MDGN) - April 7 at 12:30 PM
News IconQvt Financial Lp buys $3.9 Million stake in Medgenics Inc (MDGN) - Street Edition (NYSEMKT:MDGN) - April 5 at 1:31 PM
News IconAfter Last Week What Do Analysts Think Of Medgenics, Inc. (MDGN) - Share Trading News (NYSEMKT:MDGN) - April 3 at 1:31 PM
News IconMEDGENICS INC (NYSE:MDGN): Analysts Maintain an average rating of Strong Buy - Hints News Network (NYSEMKT:MDGN) - April 1 at 1:52 PM logoNew Broker Ratings For Medgenics, Inc. (MDGN) - FTSE News (NYSEMKT:MDGN) - March 31 at 2:19 PM
News IconMedgenics Incorporated (NYSEMKT:MDGN) Sellers Covered 3.43% of Their Shorts - Stock Caller (NYSEMKT:MDGN) - March 30 at 1:15 PM
News IconOpaleye Management buys $6.3 Million stake in Medgenics Inc (MDGN) - Los Angeles Mirror (NYSEMKT:MDGN) - March 30 at 1:15 PM


Last Updated on 10/25/2016 by Staff